Company Description

Alithea develops HLA immunopeptidomics tools for cancer immunotherapy research. Their flagship platform, HLA-Compass is the world's largest HLA-peptide database, enabling neoantigen discovery, TCR target validation, and off-target safety profiling for BioPharma and cancer vaccine developers.